Last reviewed · How we verify
NCT04141787
Ceftriaxone as Home IV for Staph Infections
Phase 4 trial testing Ceftriaxone in Staphylococcal Infections in 310 participants. Status unknown.
Quick facts
| Lead sponsor | Vancouver Island Health Authority |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Enrollment | 310 |
| Start date | 11 July 2019 |
| Estimated completion | 30 March 2024 |
Drugs / interventions tested
- Ceftriaxone (ceftriaxone) — full drug profile →
- Usual Antibiotics (Cloxacillin, Cefazolin, Daptomycin) — full drug profile →
Conditions studied
- Staphylococcal Infections — all drugs for Staphylococcal Infections →
- Osteomyelitis — all drugs for Osteomyelitis →
- CNS Infection — all drugs for CNS Infection →
- Septic Arthritis — all drugs for Septic Arthritis →
Sponsor
Vancouver Island Health Authority — full company profile →
Who can join
Eligibility, any sex, with Staphylococcal Infections or Osteomyelitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04141787
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ceftriaxone
Trials testing the same drug.
- NCT05980871 — Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline · Phase 4 · terminated
- NCT05470517 — Antibiotic Instillation in Appendicitis · Phase 2 · completed
- NCT05294588 — Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae · Phase 2 · completed
- NCT05149287 — PROPER Trial of Pain and Inflammation After Knee Arthroscopy · Phase 2 · terminated
- NCT05079620 — Early Antibiotics After Aspiration in ICU Patients · Phase 4 · terminated
Other recruiting trials for Staphylococcal Infections
Currently open trials in the same condition.
- NCT06479837 — Modeling Host-Pathogen Interaction Using Lymphoid Organoids · recruiting
- NCT05899140 — Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial · Phase 4 · recruiting
Other Vancouver Island Health Authority trials
Trials by the same sponsor.
- NCT05404204 — The Efficacy and Safety of a Novel Adjunctive Pacing Strategy During Rotational Atherectomy · unknown
- NCT04670783 — Surgery and Neuroablative Procedures in Spasticity · completed
- NCT03834051 — Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO · NA · terminated
- NCT03834038 — Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04141787 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vancouver Island Health Authority
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04141787.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing